1-1 of 1
Michael Tortorici, PhD PharmD
Close
Sort by
Journal Articles

Bleeding Risk Reduction in Relation to Predicted Factor IX Levels in Hemophilia B Patients Receiving Idelvion (rIX-FP)

John Roberts, PhD, Cecilia Fosser, PhD, Michael Tortorici, PhD PharmD, Alex Veldman, MD, Iris C. Jacobs, MD, Jagdev Sidhu, PhD
Journal: Blood
Blood (2016) 128 (22): 1411.
https://doi.org/10.1182/blood.V128.22.1411.1411
Published: 2016